Effect of IMOD in the treatment of stroke
Phase 3
- Conditions
- Acute Ischemic Stroke.occlusion and stenosis of cerebral and precerebral arteries, resulting in cerebral infarction
- Registration Number
- IRCT201108202195N2
- Lead Sponsor
- Vice Chancellor for Research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
all patients with acute ischemic stroke (based on clinical and imaging findings)
Exclusion criteria: age less than 18years or more than 80 years, prior neurological deficit of any cause, cancer or any other severe disease, rapidly improving symptoms prior to intervention, NIHSS less than 5 at disease presentation, symptom onset less than 3 hours or more than 24 hours, no informed consent, concurrent immunosuppressive / immunomodulator drug use.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method